Venus Medtech (Hangzhou) Inc. (VMTHF)

USD 0.01

(0.0%)

Annual Income Statements

(In CNY)
Breakdown 2023 2022 2021 2020 2019
Revenue 491.37 Million 406.46 Million 415.86 Million 276.04 Million 233.27 Million
Cost of Revenue 102.16 Million 92.46 Million 91.51 Million 48.76 Million 38.6 Million
Gross Profit 389.2 Million 313.99 Million 324.34 Million 227.28 Million 194.66 Million
Operating Expenses 389.2 Million 948.88 Million 596.3 Million 376.13 Million 573.35 Million
Selling, General and Administrative Expenses 454.26 Million 452.56 Million 344.65 Million 238.63 Million 322.17 Million
Research and Development Expenses 524.91 Million 527.45 Million 258.33 Million 167.25 Million 200.53 Million
Other Expenses - -557.29 Million -387.33 Million -121.61 Million -
Cost and Expenses 1.08 Billion 1.04 Billion 687.81 Million 424.9 Million 611.96 Million
Operating Income -589.97 Million -1.08 Billion -621.52 Million -237.24 Million -328.04 Million
Interest Expense 62.71 Million 44.62 Million 1.9 Million 2.15 Million 9.01 Million
Income Tax Expense -6.28 Million -34.3 Million -6.16 Million -2.97 Million 778 Thousand
Earnings before Tax -735.34 Million -1.15 Billion -377.55 Million -185.84 Million -381.54 Million
Net Income -703.75 Million -1.05 Billion -373.63 Million -181.98 Million -380.72 Million
Earnings Per Share Basic -1.61 -2.42 -0.85 -0.44 -1.22
Earnings Per Share Diluted -1.61 -2.42 -0.85 -0.44 -1.22
Weighted Average Shares Outstanding 437.89 Million 437.89 Million 438.57 Million 409.26 Million 311.03 Million
Weighted Average Shares Outstanding (Diluted) 437.89 Million 437.89 Million 438.57 Million 409.26 Million 311.03 Million
Gross Margin 0.79 0.77 0.78 0.82 0.83
EBIT Margin -1.11 -2.40 -1.37 -0.72 -1.32
Profit Margin -1.43 -2.60 -0.90 -0.66 -1.63
EBITDA -547.83 Million -999.36 Million -324.02 Million -145.97 Million -307.8 Million
Earnings Before Tax Margin -1.20 -2.68 -1.49 -0.86 -1.41

Income Statement Charts